Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS        
Revenue, net $ 1,581,000 $ 348,000 $ 2,734,000 $ 759,000
Cost of revenue 1,122,000 336,000 1,980,000 684,000
Gross profit 459,000 12,000 754,000 75,000
Operating Expenses:        
Research and development 1,305,000 904,000 2,478,000 2,038,000
Sales and marketing 975,000 510,000 1,849,000 1,208,000
General and administrative 988,000 607,000 1,956,000 1,498,000
Total operating expenses 3,268,000 2,021,000 6,283,000 4,744,000
Loss from operations (2,809,000) (2,009,000) (5,529,000) (4,669,000)
Interest expense (3,000) (1,352,000) (6,000) (1,389,000)
Change in fair value of warrant liability 0 5,000 0 24,000
Other expense (5,000) (39,000) (7,000) (41,000)
Warrant inducement expense (579,000) 0 (1,146,000) 0
Loss before provision for income taxes (3,396,000) (3,395,000) (6,688,000) (6,075,000)
Provision for income taxes 2,000 3,000 2,000 3,000
Net loss (3,398,000) (3,398,000) (6,690,000) (6,078,000)
Convertible preferred stock dividend (14,000) (20,000) (34,000) (40,000)
Deemed dividend on exchange of convertible preferred stock for common stock (1,192,000) 0 (1,192,000) 0
Deemed dividend from warrant repricing 0 (134,000) 0 (134,000)
Net loss attributable to common stockholders $ (4,604,000) $ (3,552,000) $ (7,916,000) $ (6,252,000)
Net loss per common share - basic and diluted $ (0.42) $ (0.90) $ (0.76) $ (2.42)
Weighted average number of common shares used in computing net loss per common share 10,862,074 3,936,457 10,423,469 2,583,528